ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,445Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 274

$1.24M Total Retail Price of All Prescriptions

Rank: 10 out of 274

782 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 782 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 6,389 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 50%.

Prescription Price

$167 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 580 494 1 1
SYNTHROID 491 453 2 2
METFORMIN HCL 454 401 3 3
PEN NEEDLE 341 295 4 4
SIMVASTATIN 264 241 5 8
LANTUS SOLOSTAR 261 207 6 6
NOVOLOG MIX 70-30 FLEXPEN 250 229 7 25
NOVOLOG FLEXPEN 228 196 8 12
LEVEMIR FLEXPEN 176 157 9 23
INSULIN SYRINGE 156 138 10 9
ONGLYZA 149 148 11 33
PRAVASTATIN SODIUM 142 124 12 24
GLYBURIDE 125 112 R 13 27
NOVOLOG 122 86 14 13
GLIMEPIRIDE 120 109 15 5
CRESTOR 115 115 16 17
KOMBIGLYZE XR 114 92 17 85
TRADJENTA 114 104 17 59
LISINOPRIL 96 79 19 14
GLIPIZIDE ER 94 78 20 52
LOVASTATIN 93 71 21 57
LANTUS 88 70 22 7
NOVOLOG MIX 70-30 87 72 23 31
DIOVAN 85 78 24 48
BYDUREON 84 55 25 95
GLIPIZIDE XL 81 81 26 88
METFORMIN HCL ER 81 78 26 15
ATORVASTATIN CALCIUM 77 68 28 20
BYETTA 77 44 28 41
VICTOZA 3-PAK 75 55 30 42
HYDROCORTISONE 75 57 30 82
ALENDRONATE SODIUM 72 72 32 38
HUMALOG MIX 75-25 69 52 33 26
GABAPENTIN 67 47 34 30
LEVEMIR 64 48 35 39
NOVOLIN N 62 56 36 58
HUMALOG 57 45 37 11
NOVOFINE 32 52 46 38 55
ACTOS 52 46 38 29
SENSIPAR 52 52 38 131
GLIPIZIDE 52 48 38 18
NOVOLIN 70-30 51 51 42 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.